Key Takeaways DexCom's Q3 EPS of 61 cents beat estimates, with revenue up 21.6% to $1.21 billion.Strong CGM demand and new access wins drove gains in type 2 diabetes coverage.DexCom raised 2025 revenue guidance to $4.63$4.65B, implying 15% year-over-year growth.DexCom, Inc. (DXCM) reported third-quarter 2025 adjusted earnings per share (EPS) of 61 cents, which beat the Zacks Consensus Estimate of 57 cents by 7%. The company reported earnings of 45 cents per share in the prior-year quarter.DXCM registered GA ...